Yangambin and Epi-yangambin Isomers: New Purification Method from Ocotea fasciculata and First Cytotoxic Aspects Focusing on In Vivo Safety

 

 Buy Article Permissions and Reprints

Abstract

Ocotea fasciculata presents yangambin (YAN) and its isomer epi-yangambin (EPI-YAN) as major lignans, which are employed as the plant markers for quality control purposes and as potential pharmacological compounds. However, a gap between the pure isomers and safety and efficacy protocols is faced by the scientific community. In this context, this work aimed to report (i) a new and advantageous purifying process in a semi-preparative scale for YAN and EPI-YAN isolation from Ocotea fasciculata, and (ii) an in vitro cytotoxicity study to estimate, for the first time, the LD₅₀ values of the isolated epimers, as well as the influence of albumin concentration in cell culture medium. The best condition for epimers isolation was achieved in normal-phase liquid chromatography. The lignan fraction (LF), previously obtained from the plant ethanolic extract, was purified yielding 17% and 29% of YAN and EPI-YAN, respectively. The in vitro study demonstrated that YAN and EPI-YAN were safe, and only at the highest concentration studied, a decrease on cell viability was observed. The estimated LD₅₀ value was higher than 1612 mg/kg for both epimers. The LF, on the other hand, demonstrated an estimated LD₅₀ of 422 mg/kg. Lignan cytotoxicity studies also evidenced that the higher cell viability was related to the higher concentration of fetal bovine serum as a source of albumin in medium. This is the first time the LD₅₀ and safety of the isolated epimers were estimated, opening up great perspectives of success in in vivo studies.

• References

• 1 Barbosa-Filho JM, Vargas MRW, Silva IG, França IS, Morais LCSL, Cunha EVL, Silva MS, Souza MFV, Chaves MCO, Almeida RN, Agra MF. Ocotea duckei: exceptional source of YAN and other furofuran lignans. An Acad Bras Ciênc 1999; 71: 231-238
  PubMedGoogle Scholar
• 2 Morais LCSL, Barbosa-Filho JM, Almeida RN, Cunha EVL, Silva MS. Further lignans from Ocotea duckei . Pharm Biol 1999; 37: 144-147
  CrossrefPubMedGoogle Scholar
• 3 Gottlieb OR. Chemosystematics of the Lauraceae. Phytochemistry 1972; 11: 1537-1570
  CrossrefPubMedGoogle Scholar
• 4 Gottlieb OR, Yoshida M. Lignans. In: Rowe JW. ed. Natural Products of woody Plants. Berlin: Springer; 1989: 439-511
  CrossrefGoogle Scholar
• 5 Monte Neto RL, Sousa LM, Dias CS, Barbosa-Filho JM, Oliveira MR, Figueiredo RC. Morphological and physiological changes in Leishmania promastigotes induced by yangambin, a lignan obtained from Ocotea duckei . Exp Parasitol 2011; 127: 215-221
  CrossrefPubMedGoogle Scholar
• 6 Marquele-Oliveira F, Torres EC, Barud HS, Zoccal KF, Faccioli LH, Hori JI, Berretta AA. Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product. J Pharm Biom Anal 2016; 123: 195-204
  CrossrefPubMedGoogle Scholar
• 7 Rossetti FC, Leal SS, Filho JMB, Oliveira EJ, Barud HS, Hori JI, Marquele-Oliveira F, Berretta AA. Challenges in developing a safe nanomedicine based on Ocotea Duckei Vattimo to leishmaniasis treatment: methodology, nanoparticle development and cytotoxicity assays. Pharm Nanotechnol 2014; 2: 101-114
  PubMedGoogle Scholar
• 8 Araújo ISGA, Silva DF, de Alustau MC, Dias KLG, Cavalcante KVM, Veras RC, Barbosa-Filho JM, Neto MA, Bendhack LM, Correia NA, Medeiros IA. Calcium influx inhibition is involved in the hypotensive and vasorelaxant effects induced by yangambin. Molecules 2014; 19: 6863-6876
  CrossrefPubMedGoogle Scholar
• 9 Barbosa-Filho JM, Cunha RM, Dias CS, Athayde-Filho PF, Silva MS, Cunha EVL, Machado MIL, Craveiro AA, Medeiros IA. GC-MS Analysis and cardiovascular activity of the essential oil of Ocotea duckei . Braz J Pharmacogn 2008; 18: 37-41
  PubMedGoogle Scholar
• 10 Serra MF, Diaz BL, Barreto EO, Pereira APB, Lima MCR, Barbosa-Filho JM, Cordeiro RSB, Martins MA, Silva PMR. Anti-allergic properties of the natural PAF antagonist yangambin. Planta Med 1997; 63: 207-212
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Sousa FCF, Pereira BA, Lima VTM, Lacerda CDG, Melo CTV, Barbosa-Filho JM, Vasconcelos SMM, Viana GSB. Central nervous system activity of yangambin from Ocotea duckei Vattimo (Lauraceae) in mice. Phytother Res 2005; 19: 282-286
  CrossrefPubMedGoogle Scholar
• 12 Tibiriça EV, Mosquera K, Abreu M, Ribeiro R, Carvalho FAS, Barbosa-Filho JM, Cordeiro RSB. Antagonistic effect of yangambin on platelet-activating factor (PAF)-induced cardiovascular collapse. Phytomedicine 1996; 2: 235-242
  CrossrefPubMedGoogle Scholar
• 13 Castro-Faria-Neto HC, Araujo CV, Bozza PT, Thomas G, Barbosa-Filho JM, Cordeiro RS, Tibiriçá EV. Yangambin: A new naturally-occurring platelet-activating factor receptor antagonist: in vivo pharmacological studies. Planta Med 1995; 61: 106-112
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Latif Z, Sarker SD. Isolation of natural products by preparative high performance liquid chromatography (Prep-HPLC). Methods Mol Biol 2012; 864: 255-274
  PubMedGoogle Scholar
• 15 Cox G. Preparative Separation. In: Snyder LR, Kirkland JJ, Dolan JW. eds. Introduction to modern liquid Chromatography. 3rd edition. New Jersey: John Wiley & Sons; 2010: 725-756
  Google Scholar
• 16 Monte Neto RL, Sousa LM, Dias CS, Filho JM, Oliveira MR. Yangambin cytotoxicity: a pharmacologically active lignan obtained from Ocotea duckei Vattimo (Lauraceae). Z Naturforsch C 2008; 63: 681-686
  PubMedGoogle Scholar
• 17 Organization for Economic Co-operation and Development (OECD). Series on testing and assessment. Guidance Document on Using Cytotoxicity Test to Estimate Starting doses for Acute Oral Systemic Toxicity Test. Paris 2010; 129: 30-32
  PubMedGoogle Scholar
• 18 Guillarme D, Nguyen DTT, Rudaz S, Veuthey JL. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part I: Isocratic separation. Eur J Pharm Biopharm 2007; 66: 475-482
  CrossrefPubMedGoogle Scholar
• 19 Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-124
  CrossrefPubMedGoogle Scholar
• 20 Rampersad SN. Multiple applications of alamar blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors 2012; 12: 12347-12360
  CrossrefPubMedGoogle Scholar
• 21 United Nations. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 2nd ed.. ed. New York and Geneva: United Nations; 2007
  Google Scholar
• 22 Sichaem J, Surapinit S, Siripong P, Khumkratok S, Jong-aramruang J, Tip-pyang S. Two new cytotoxic isomeric indole alkaloids from the roots of Nauclea orientalis . Fitoterapia 2010; 81: 830-833
  CrossrefPubMedGoogle Scholar
• 23 Finlay GJ, Baguley BC. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Cancer Chemother Pharmacol 2000; 45: 417-422
  CrossrefPubMedGoogle Scholar
• 24 Gülden M, Mörchel S, Tahan S, Seibert H. Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro . Toxicology 2002; 175: 201-213
  CrossrefPubMedGoogle Scholar
• 25 Seibert H, Mörchel S, Gülden M. Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration. Toxicol In Vitro 2002; 16: 289-297
  CrossrefPubMedGoogle Scholar
• 26 Brazilian Health Regulatory Agency (ANVISA). Available at. http://portal.anvisa.gov.br/documents/10181/2721567/RDC_166_2017_COMP.pdf/d5fb92b3-6c6b-4130-8670-4e3263763401 Accessed April 15, 2019
  PubMedGoogle Scholar
• 27 Wang C, Williams NS. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. J Pharm Biom Anal 2013; 75: 112-117
  CrossrefPubMedGoogle Scholar

• Supplementary Material